fda warning about compounded semaglutide The growing availability of GLP-1 weight-loss drugs has prompted warnings from doctors and the U.S. Food and Drug Administration. https://www.abc27.com/national/compounded -glp-1-drugs-creating-concern-among-doctors-and-fda/?utm_medium FDA alerts health care providers,

M.(2022)

Confirm the prescription is written in English

The share who report ever taking these drugs rises to four in ten (43%) among adults who have been told by a doctor that they have diabetes, a quarter who have been told they have heart disease, and one in five (22%) who have been told by a doctor that they are overweight or obese in the past five years 1

We don't know the price yet, but let's be realistic

Keep an Eye on Progress Try using tools like journals, photos, or body scanners to track your journey outside of just measuring weight

My doctor thought the lab work was a mistake because my lipid panel looked better than it had in two decades